Skip to main content
Tetra Bio-Pharma Inc. logo

Tetra Bio-Pharma Inc. — Investor Relations & Filings

Ticker · TBPMQ ISIN · CA88166Y1007 LEI · 5299000CYH3P8XC2UO53 TSX Manufacturing
Open in API
Filings indexed 720 across all filing types
Latest filing 2022-03-17 Regulatory Filings
Country CA Canada
Listing TSX TBPMQ

About Tetra Bio-Pharma Inc.

https://tetrabiosciences.com/

Tetra Bio-Pharma is a biopharmaceutical company specializing in the discovery and development of cannabinoid-derived drugs and medicinal plant-based products. The company maintains an advanced pipeline encompassing biopharmaceuticals, natural health, and veterinary products. Clinical programs are focused on therapeutic areas such as inflammation, pain management (including alternatives to opioids), and ophthalmology. Tetra emphasizes rigorous clinical trials and scientific evidence, utilizing novel approaches, unique mechanisms of action, and high-quality delivery methods to address unmet patient needs.

Recent filings

Filing Released Lang Actions
News release - English.pdf
Regulatory Filings
2022-03-17 English
News release - English.pdf
Regulatory Filings Classification · 95% confidence The document is a press release providing an update on a research collaboration between Tetra Bio-Pharma and the University of Montreal Hospital Research Centre regarding a clinical trial on inhaled CBD. It discusses the approval of a phase I study amendment by Health Canada, details about the clinical trial, and background information on the collaborators. There are no financial statements, earnings data, regulatory filings, or management changes. The content is informational about ongoing research and clinical trial progress, not a financial report or regulatory filing. It is not an announcement of a report publication but a standalone update. Therefore, it fits best under Regulatory Filings (RNS) as a general regulatory announcement and company update that does not fit other specific categories.
2022-03-08 English
News release - English.pdf
Management Reports Classification · 95% confidence The document is a detailed management update from Tetra Bio-Pharma discussing operational focus, clinical trial progress, financial management, intangible asset impairment, and business strategy. It references the Management Discussion and Analysis (MD&A) fiscal year-end report and provides substantive information on clinical trials, drug development, and financial impacts such as impairment of intangible assets. The content includes detailed explanations of business trends, financial conditions, and outlook, which are characteristic of a Management Discussion and Analysis report. It is not a brief announcement, certification, or a simple regulatory filing. Therefore, the document fits best under the category of Management Reports (MDA).
2022-03-01 English
Annual information form - English.pdf
Regulatory Filings Classification · 95% confidence The document is titled 'Annual Information Form For the year ended November 30, 2021' and dated February 28, 2022. It contains detailed sections typical of an Annual Information Form (AIF), including corporate structure, business overview, risk factors, capital structure, directors and management, audit committee information, legal proceedings, and other comprehensive disclosures. The document is lengthy (15,000 characters) and includes substantive content beyond a mere announcement or summary. An Annual Information Form is a regulatory filing commonly used in Canadian securities regulation to provide detailed information about a company, similar to but distinct from an Annual Report (10-K). Given the detailed nature and the title, this document fits best under the category of Regulatory Filings (RNS) because the AIF is a specific regulatory filing distinct from the Annual Report (10-K) and other categories. It is not an Annual Report (10-K) because it does not present full financial statements and performance but rather detailed corporate and business information as required by securities regulators. Therefore, the most appropriate classification is Regulatory Filings (RNS).
2022-02-28 English
52-109F1 - Certification of annual filings - CFO (E).pdf
Regulatory Filings Classification · 95% confidence The document is a Form 52-109F1 Certification of Annual Filings Full Certificate by a financial officer of Tetra Bio-Pharma Inc. It certifies the review and fair presentation of the annual filings for the financial year ended November 30, 2021, including the AIF, annual financial statements, and annual MD&A. The document is primarily an officer certification attesting to the accuracy and completeness of the annual filings and the effectiveness of disclosure controls and internal controls over financial reporting. It does not contain the actual financial statements or substantive financial data itself, but rather certifies the filings. According to the Certification Rule, such officer certifications should be classified as Regulatory Filings (RNS) rather than as the Annual Report (10-K) or Management Reports (MDA). The document length is about 5,052 characters, which is consistent with a certification letter rather than a full report. Therefore, the appropriate classification is Regulatory Filings (RNS).
2022-02-28 English
52-109F1 - Certification of annual filings - CEO (E).pdf
Regulatory Filings Classification · 100% confidence The document is a Form 52-109F1 Certification of Annual Filings Full Certificate by the CEO of Tetra Bio-Pharma Inc. It certifies the review and fair presentation of the annual filings for the financial year ended November 30, 2021. The content is primarily an officer certification regarding the accuracy and completeness of the annual filings, disclosure controls, and internal control over financial reporting (ICFR). It does not contain actual financial statements or substantive financial data but is a formal attestation as required by securities legislation. According to the Certification Rule, such officer certifications should be classified as Regulatory Filings (RNS) rather than the actual annual report or financial statements themselves.
2022-02-28 English

Browse filings by year

15 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.